JP2005505550A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505550A5
JP2005505550A5 JP2003524585A JP2003524585A JP2005505550A5 JP 2005505550 A5 JP2005505550 A5 JP 2005505550A5 JP 2003524585 A JP2003524585 A JP 2003524585A JP 2003524585 A JP2003524585 A JP 2003524585A JP 2005505550 A5 JP2005505550 A5 JP 2005505550A5
Authority
JP
Japan
Prior art keywords
lower alkyl
heterocyclyl
aryl
optionally substituted
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003524585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005505550A (ja
JP4131701B2 (ja
Filing date
Publication date
Priority claimed from GBGB0121026.9A external-priority patent/GB0121026D0/en
Priority claimed from GB0121024A external-priority patent/GB0121024D0/en
Application filed filed Critical
Priority claimed from PCT/EP2002/009661 external-priority patent/WO2003020278A1/en
Publication of JP2005505550A publication Critical patent/JP2005505550A/ja
Publication of JP2005505550A5 publication Critical patent/JP2005505550A5/ja
Application granted granted Critical
Publication of JP4131701B2 publication Critical patent/JP4131701B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003524585A 2001-08-30 2002-08-29 炎症および他の疾患を処置するための、2−シアノ−4−アミノ−ピリミジン構造およびカテプシンk阻害活性を有するシステインプロテアーゼインヒビター Expired - Fee Related JP4131701B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0121026.9A GB0121026D0 (en) 2001-08-30 2001-08-30 Organic compounds
GB0121024A GB0121024D0 (en) 2001-08-30 2001-08-30 Organic compounds
PCT/EP2002/009661 WO2003020278A1 (en) 2001-08-30 2002-08-29 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases

Publications (3)

Publication Number Publication Date
JP2005505550A JP2005505550A (ja) 2005-02-24
JP2005505550A5 true JP2005505550A5 (https=) 2005-11-17
JP4131701B2 JP4131701B2 (ja) 2008-08-13

Family

ID=26246490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524585A Expired - Fee Related JP4131701B2 (ja) 2001-08-30 2002-08-29 炎症および他の疾患を処置するための、2−シアノ−4−アミノ−ピリミジン構造およびカテプシンk阻害活性を有するシステインプロテアーゼインヒビター

Country Status (22)

Country Link
US (2) US7112589B2 (https=)
EP (1) EP1423121B1 (https=)
JP (1) JP4131701B2 (https=)
KR (1) KR100629834B1 (https=)
CN (1) CN1549717B (https=)
AR (1) AR036375A1 (https=)
AT (1) ATE345136T1 (https=)
AU (1) AU2002333758B2 (https=)
BR (1) BR0212141A (https=)
CA (1) CA2456127C (https=)
CO (1) CO5560576A2 (https=)
DE (1) DE60216122T2 (https=)
ES (1) ES2275946T3 (https=)
HU (1) HUP0401431A3 (https=)
IL (1) IL160295A0 (https=)
MX (1) MXPA04001930A (https=)
NZ (1) NZ531287A (https=)
PE (1) PE20030772A1 (https=)
PL (1) PL208280B1 (https=)
PT (1) PT1423121E (https=)
RU (1) RU2326119C2 (https=)
WO (1) WO2003020278A1 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
SE0201976D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
SE0201980D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
TW200510436A (en) * 2003-07-21 2005-03-16 Novartis Ag Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
WO2005011703A1 (en) * 2003-08-04 2005-02-10 Akzo Nobel N.V. 2-cyano-1,3,5-triazine-4,6-diamine derivatives
WO2005030128A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Pyrazole modulators of metabotropic glutamate receptors
CN1882343A (zh) * 2003-11-19 2006-12-20 诺瓦提斯公司 组织蛋白酶k抑制剂在严重骨损失疾病中的用途
JPWO2005103012A1 (ja) * 2004-04-21 2008-03-13 小野薬品工業株式会社 ヒドラジノ複素環ニトリル化合物およびその用途
TW200614993A (en) 2004-06-11 2006-05-16 Akzo Nobel Nv 4-phenyl-pyrimidine-2-carbonitrile derivatives
TW200624429A (en) * 2004-09-07 2006-07-16 Glaxo Group Ltd Novel cysteine protease inhibitors
WO2006040300A1 (en) * 2004-10-12 2006-04-20 N.V. Organon 4-cycloalkyl-pyrimidine-2-carbonitrile derivatives
IL164942A0 (en) * 2004-10-31 2005-12-18 Yeda Res & Dev The use of a protease or a protease inhibitor for the manufacture of medicaments
GB0514684D0 (en) * 2005-07-18 2005-08-24 Novartis Ag Organic compounds
CA2617725C (en) * 2005-08-05 2012-04-03 Hybrigenics Sa Novel cysteine protease inhibitors and their therapeutic applications
AR057110A1 (es) * 2005-09-02 2007-11-14 Glaxo Group Ltd DERIVADOS DE HETEROARIL-NITRILOS SUSTITUíDOS QUE SON INHIBIDORES DE PROTEASAS
US7326715B2 (en) 2005-09-23 2008-02-05 N.V. Organon 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
TW200745055A (en) * 2005-09-23 2007-12-16 Organon Nv 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
US7687515B2 (en) 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
AU2007253796A1 (en) * 2006-05-22 2007-11-29 Velcura Therapeutics, Inc. Use of Cathepsin K antagonists in bone production
US20090227579A1 (en) * 2006-06-23 2009-09-10 Astrazeneca Ab Pteridine Derivatives and their Use as Cathespin Inhibitors
EP1947091A1 (en) * 2007-01-16 2008-07-23 Glaxo Group Limited Pyrimidyl nitrile derivatives as cysteine protease inhibitors
US7932251B2 (en) 2007-07-16 2011-04-26 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
KR101595238B1 (ko) 2007-12-21 2016-02-18 리간드 파마슈티칼스 인코포레이티드 선택적 안드로겐 수용체 조절제(sarm) 및 이의 용도
EP2719700A1 (en) 2008-01-09 2014-04-16 Amura Therapeutics Limited Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases
TW201035094A (en) 2009-01-16 2010-10-01 Organon Nv 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
US8026236B2 (en) 2009-01-16 2011-09-27 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
EP2316820A1 (en) * 2009-10-28 2011-05-04 Dompe S.p.A. 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
WO2011086125A1 (en) 2010-01-15 2011-07-21 N.V. Organon 1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES
CN108192972B (zh) 2010-10-06 2022-09-09 生物医学研究机构基金会 用于乳腺癌转移的诊断、预后和治疗的方法
US8524710B2 (en) * 2010-11-05 2013-09-03 Hoffmann-La Roche Inc. Pyrrolidine derivatives
EP2650682A1 (en) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Method for the prognosis and treatment of cancer metastasis
BR112014030750A2 (pt) 2012-06-06 2017-08-22 Inst Catalana Recerca Estudis Avancats Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
ES2906586T3 (es) 2012-10-12 2022-04-19 Inbiomotion Sl Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
WO2014184679A2 (en) 2013-03-15 2014-11-20 Inbiomotion S.L. Method for the prognosis and treatment of renal cell carcinoma metastasis
CA2906394A1 (en) 2013-03-15 2014-09-18 Fundacio Institut De Recerca Biomedica (Irb Barcelona) Method for the prognosis and treatment of cancer metastasis
DK3055429T3 (en) 2013-10-09 2019-04-23 Fundacio Inst De Recerca Biomedica Irb Barcelona Procedure for the prognosis and treatment of metastatic bone cancer resulting from breast cancer
EP3094323A4 (en) 2014-01-17 2017-10-11 Ligand Pharmaceuticals Incorporated Methods and compositions for modulating hormone levels
KR20170093182A (ko) 2014-12-11 2017-08-14 인바이오모션 에스.엘. 인간 c-maf에 대한 결합 구성원
US11596642B2 (en) 2016-05-25 2023-03-07 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-MAF status
US11160801B2 (en) * 2017-01-27 2021-11-02 Genfit RORgamma modulators and uses thereof
CN108586356B (zh) * 2017-03-16 2021-02-19 杭州科巢生物科技有限公司 瑞博西尼新中间体及其制备瑞博西尼的合成方法
KR20200104298A (ko) 2017-11-22 2020-09-03 인바이오모션 에스.엘. c-MAF 상태에 기반한 유방암의 요법 치료
CN109467536B (zh) * 2018-12-23 2020-06-05 沧州普瑞东方科技有限公司 2-氯/羟基嘧啶-5-羧酸的合成方法
AU2020250933A1 (en) 2019-04-05 2021-10-28 Centre Hospitalier Régional Et Universitaire De Brest Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
AU2020257397B2 (en) 2019-04-19 2026-02-26 Ligand Pharmaceuticals Inc. Crystalline forms and methods of producing crystalline forms of a compound

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE609808A (https=) 1960-11-02
NL295648A (https=) * 1962-07-26
BR6915234D0 (pt) 1969-05-22 1973-06-07 American Cyanamid Co Novos derivados de melamina e processo para sua preparaca
CH627919A5 (de) * 1977-04-14 1982-02-15 Ciba Geigy Ag Herbizide mittel.
CA2230894A1 (en) * 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
US6313127B1 (en) 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
DE19817459A1 (de) 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
YU17402A (sh) 1999-09-13 2004-11-25 Boehringer Ingelheim Pharmaceuticals Inc. Nova spiroheterociklična jedinjenja upotrebljiva kao reverzibilni inhibitori cisteinskih proteaza
EP1219609B1 (en) * 1999-09-16 2007-04-04 Tanabe Seiyaku Co., Ltd. Aromatic nitrogenous six-membered ring compounds
NZ522217A (en) * 2000-04-28 2004-04-30 Tanabe Seiyaku Co Cyclic compounds
GB0013383D0 (en) 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
SE0201976D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
SE0201980D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds

Similar Documents

Publication Publication Date Title
JP2005505550A5 (https=)
CO5560576A2 (es) Inhibidores de proteasa de cisteina con estructura de 2- ciano 4-amino-pirimidina y actividad inhibidora de captesina k para el tratamiento de inflamaciones y otras enfermedades
ES2555308T3 (es) Derivado de tiazol
CO5200785A1 (es) Uso terapeutico de quinazolina
AR065276A1 (es) Herbicidas de n-oxidos de piridina sustituidos
IT1251376B (it) Pregna 1,4-diene-3,20-dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
JP2009530424A5 (https=)
JP2008540687A5 (https=)
JP2005508961A5 (https=)
AR087051A2 (es) Una composicion inhibidora del virus de la hepatitis c y uso
RU2009115963A (ru) Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами
AR049388A1 (es) Heterociclos como inhibidores de aldosterona sintasa
RU2004109815A (ru) Пирролопиримидины в качестве средств ингибирования цистеинпротеаз
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
AR052458A1 (es) Amino-imidazolonas para la inhibicion de beta-secretasa
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
JP2007501779A5 (https=)
JP2007511527A5 (https=)
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
PL322419A1 (en) Novel substituted compounds of biphenyl or phenylopyridine, method of obtaining them as well as pharmaceutic compositions containing such compounds
AR035732A1 (es) Derivados cromen-2-carboxilicos terapeuticos, uso de estos derivados para la preparacion de medicamentos, composicion farmaceutica, compuestos relacionados, y procesos para preparar estos compuestos relacionados
JP2006528617A5 (https=)
JP2005525364A5 (https=)
AR047274A1 (es) Derivados de oxazoltetraciclinas como antibioticos. metodos de obtencion y composiciones farmaceuticas.